HERON THERAPEUTICS, INC. /DE/ — Net Income by Fiscal Year

17 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/2e4e0120-62d9-4277-b07d-8d525eb2d00f/serie/net-income

Fiscal year	Net Income	Period	Evidence
FY 2025	$-20.0M	2025-01-01 – 2025-12-31	evidence 0001193125-26-164270
FY 2024	$-14.0M	2024-01-01 – 2024-12-31	evidence 0001193125-26-164270
FY 2023	$-111.0M	2023-01-01 – 2023-12-31	evidence 0001193125-26-164270
FY 2022	$-182.0M	2022-01-01 – 2022-12-31	evidence 0001193125-26-164270
FY 2021	$-221.0M	2021-01-01 – 2021-12-31	evidence 0001193125-26-164270
FY 2020	$-227.3M	2020-01-01 – 2020-12-31	evidence 0001564590-21-007841
FY 2019	$-204.7M	2019-01-01 – 2019-12-31	evidence 0001564590-20-007973
FY 2018	$-178.8M	2018-01-01 – 2018-12-31	evidence 0001193125-19-047780
FY 2017	$-197.5M	2017-01-01 – 2017-12-31	evidence 0001193125-18-060951
FY 2016	$-173.1M	2016-01-01 – 2016-12-31	evidence 0001193125-17-054088
FY 2015	$-97.6M	2015-01-01 – 2015-12-31	evidence 0001193125-16-469890
FY 2014	$-76.4M	2014-01-01 – 2014-12-31	evidence 0001193125-15-091072
FY 2013	$-55.3M	2013-01-01 – 2013-12-31	evidence 0001193125-14-087658
FY 2012	$-23.3M	2012-01-01 – 2012-12-31	evidence 0001193125-13-085823
FY 2011	$-11.8M	2011-01-01 – 2011-12-31	evidence 0001193125-12-132146
FY 2010	$-7.3M	2010-01-01 – 2010-12-31	evidence 0001193125-12-132146
FY 2009	$-10.0M	2009-01-01 – 2009-12-31	evidence 0001193125-12-132146

Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

HERON THERAPEUTICS, INC. /DE/ — all facts · Revenue · Operating Income